Russia to stage best ever edition of FIFA Confederations Cup this year — Brazil’s CarlosSport March 24, 19:28
Jehovah’s Witnesses say they have no suspension orders from Justice Ministry yetSociety & Culture March 24, 19:10
Islamic State claims responsibility for attack on Russian Guard base in ChechnyaWorld March 24, 18:51
Eurovision organizers set to find solution for Russia's contestant to perfom in KievWorld March 24, 18:46
Russia’s Airborne Force wraps up large-scale drills in CrimeaMilitary & Defense March 24, 18:20
Russia may start Ka-52 attack helicopter deliveries to Egypt in 2nd half of yearMilitary & Defense March 24, 17:21
Ex-Russian MP’s suspected assassin’s ‘double’ pops up in UkraineWorld March 24, 16:59
Photos of the week: Putin at the theater, Trump behind the wheel and Erdogan playing ballSociety & Culture March 24, 16:39
Bank of Russia points to ruble cutting its 'oil dependency'Business & Economy March 24, 16:33
UNITED NATIONS, November 14. /TASS/. If the tests of experimental vaccines against the Ebola virus are successful, they will be available next year, UN Secretary-General’s special envoy David Nabarro said on Thursday. According to him, there are two highly promising potential vaccines. Sierra Leone’s Permanent Representative to the United Nations Vandi Chidi Minah told reporters that he expected “good news” about the results of the tests by the end of the current year.
According to the World Health Organization (WHO), the number of fatalities of the fever epidemic outbreak in West Africa has exceeded 5,100 people and 14,100 people have been infected. The situation is the most serious in Guinea, Liberia and Sierra Leone.
A number of countries are actively developing the Ebola vaccine. The UK, Japan, Russia and China have made progress in this area. On Wednesday, the international humanitarian organization Doctors Without Borders announced it would hold in December the vaccine testing in three medical centres in West Africa. Russia and China this week has allocated tens of millions of dollars for the development of the antiviral drugs.